Covid-19 treatment update: follow the scientific evidence. Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study. Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). Basic to translational science, 2 2, 146-148, Becker, Richard; Haight, Sean 2017. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Preparing for your first cancer appointment can be overwhelming. He is a medical oncologist, an associate professor at UW Medicine and an affiliate member of the Clinical Research Division of Fred Hutch. Richard L. Becker, D.O. Mon. Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AF. Early career investigator's circle: identifying and nurturing the next generation of scientists and scientific writers. The periprocedural management of novel oral anticoagulants in patients with nonvalvular atrial fibrillation: rationale and a summary of the available evidence from phase 3 clinical trials. Board Certifications: Hematology, Internal Medicine and Medical Oncology. Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes. South Asian-Specific MYBPC3?25bp Deletion Carriers Display Hypercontraction and Impaired Diastolic Function Under Exercise Stress. Effect of genetic variations on ticagrelor plasma levels and clinical outcomes. . You lie on a table where a device delivers the radiation for five to 10 minutes. Grace Patlewicz, Ted W. Simon, Katy O. Goyak, Richard D. Phillips, J. Craig Rowlands, Shawn D. Seidel, Richard A. Becker. Journal of thrombosis and thrombolysis, 37 2, 216, Breithardt, Gnter; Baumgartner, Helmut; Berkowitz, Scott D; Hellkamp, Anne S; Piccini, Jonathan P; Stevens, Susanna R; Lokhnygina, Yuliya; Patel, Manesh R; Halperin, Jonathan L; Singer, Daniel E; Hankey, Graeme J; Hacke, Werner; Becker, Richard C; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M 2014. American journal of physiology. Bazrafshan, Sholeh; Kushlaf, Hani; Kakroo, Mashhood; Quinlan, John; Becker, Richard C; Sadayappan, Sakthivel 2021. request an appointment. Are hospitals focusing enough on disaster readiness? Arteriosclerosis, thrombosis, and vascular biology, 30 3, 369-71, Povsic, Thomas J; Sullenger, Bruce A; Zelenkofske, Steven L; Rusconi, Christopher P; Becker, Richard C 2010. Journal of thrombosis and thrombolysis, 47 3, 337-344, Chen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R; Melloni, Chiara 2019. Mars atmosphere. Geophysical research letters, 40 23, 6033-6037, Xu, Weixian; Holmes, Dajuanicia N; Becker, Richard C; Roe, Matthew T; Peterson, Eric D; Wang, Tracy Y 2013. Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events. European heart journal. Nancy B. Beck, Richard A. Becker, Neeraja K. Erraguntla, William H. Farland, Roberta L. Grant, George M. Gray, Christopher R. Kirman, Judy S. LaKind, R. Jeffrey Lewis, Patricia Nance, Lynn H. Pottenger, Susan L. Santos, Stephanie Shirley, Ted W. Simon, Michael L. Dourson. American heart journal, 236 , 4-12, Carnicelli, Anthony P; Hellkamp, Anne S; Mahaffey, Kenneth W; Singer, Daniel E; Breithardt, Gnter; Halperin, Jonathan L; Hankey, Graeme J; Piccini, Jonathan P; Becker, Richard C; Nessel, Christopher C; Berkowitz, Scott D; Fox, Keith A A; Califf, Robert M; Patel, Manesh R 2021. Antithrombotic Treatment in Transcatheter Aortic Valve Implantation: Insights for Cerebrovascular and Bleeding Events. American heart journal, 186 , 91-99, Feigal, Jacob P; Boyle, Stephen H; Samad, Zainab; Velazquez, Eric J; Wilson, Jennifer L; Becker, Richard C; Williams, Redford B; Kuhn, Cynthia M; Ortel, Thomas L; Rogers, Joseph G; O'Connor, Christopher M; Jiang, Wei 2017. Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Journal of the American Heart Association, 4 3, e001349, Steinberg, Benjamin A; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Gnter; Hankey, Graeme J; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hacke, Werner; Nessel, Christopher C; Berkowitz, Scott D; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Piccini, Jonathan P 2015. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. Journal of the American Heart Association, 5 3, e002197, Povsic, Thomas J; Lawrence, Monica G; Lincoff, A Michael; Mehran, Roxana; Rusconi, Christopher P; Zelenkofske, Steven L; Huang, Zhen; Sailstad, Jeffrey; Armstrong, Paul W; Steg, P Gabriel; Bode, Christoph; Becker, Richard C; Alexander, John H; Adkinson, N Franklin; Levinson, Arnold I 2016. Looking for something else? Journal of the American College of Cardiology, 52 21, 1693-701, Chan, Mark Y; Becker, Richard C; Harrington, Robert A; Peterson, Eric D; Armstrong, Paul W; White, Harvey; Fox, Keith A A; Ohman, E Magnus; Roe, Matthew T 2008. Circulation, 129 18, 1850-9. Good laboratory practices and safety assessments. Developing scientific confidence in HTS-derived prediction models: lessons learned from an endocrine case study. is a physician in north Texas, where he and his wife, Cindy, host the daily television talk show, Your Health with Dr. Richard and Cindy Becker. European heart journal, 36 5, 288-96, Varenhorst, Christoph; Eriksson, Niclas; Johansson, sa; Barratt, Bryan J; Hagstrm, Emil; kerblom, Axel; Syvnen, Ann-Christine; Becker, Richard C; James, Stefan K; Katus, Hugo A; Husted, Steen; Steg, Ph Gabriel; Siegbahn, Agneta; Voora, Deepak; Teng, Renli; Storey, Robert F; Wallentin, Lars 2015. Impact of body mass index on markers of left ventricular thickness and mass calculation: results of a pilot analysis. 7:00 pm Central Otago 'Alexandra' Suppor. Povsic, Thomas J; Vavalle, John P; Alexander, John H; Aberle, Laura H; Zelenkofske, Steven L; Becker, Richard C; Buller, Christopher E; Cohen, Mauricio G; Cornel, Jan H; Kasprzak, Jaroslaw D; Montalescot, Gilles; Fail, Peter S; Sarembock, Ian J; Mehran, Roxana 2014. Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis. Find other locations and directions on MedicalNewsToday. Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease. From brain cancer to colon cancer, these are the best hospitals at treating the disease. European journal of preventive cardiology, , Patlewicz, Grace; Ball, Nicholas; Becker, Richard A; Booth, Ewan D; Cronin, Mark T D; Kroese, Dinant; Steup, David; van Ravenzwaay, Ben; Hartung, Thomas 2014. Journal of the American Heart Association, 2 1, e000067, Vavalle, John P; Povsic, Thomas J; Aberle, Laura H; Zelenkofske, Steven L; Mehran, Roxana; Kasprzak, Jaroslaw D; Bode, Christoph; Buller, Christopher E; Montalescot, Gilles; Cornel, Jan H; Becker, Richard C; Alexander, John H; Cohen, Mauricio G 2013. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes. The American journal of cardiology, 119 12, 1989-1996, Becker, Richard A; Dreier, David A; Manibusan, Mary K; Cox, Louis A Tony; Simon, Ted W; Bus, James S 2017. Provides clear information and answers questions in a way patients understand. Studies of the interaction of ticagrelor with the P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes. Journal of thrombosis and thrombolysis, , Becker, Richard C; Helmy, Tarek 2015. He graduated from UNIVERSITY OF CINCINNATI / MAIN CAMPUS in 1982. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. Reports have shown that -glucans exert multiple effects on cancer cells and cancer prevention. The rapid proliferation of solicited content online journals: a quest to disseminate knowledge? Please verify your coverage with the provider's office directly when scheduling an appointment. In March 2022, we expanded by adding Dr. Niraj Pahlajani as our second Radiation Oncologist. Cardiac tamponade in the fibrinolytic era: analysis of >100,000 patients with ST-segment elevation myocardial infarction. Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor. {C} Surveys in geophysics, 39 3, 543-566, Ouyang, Zutao; Qian, Song S; Becker, Richard; Chen, Jiquan 2018. Stroke; a journal of cerebral circulation, 44 8, e95-6, Krishnan, Anandi; Vogler, Erwin A; Sullenger, Bruce A; Becker, Richard C 2013. Read-across approaches - misconceptions, promises and challenges ahead. John Doull, Joseph F. Borzelleca, Richard A. Becker, George P. Daston, John M. DeSesso, Anna Fan, Penelope A. Fenner-Crisp, Michael P. Holsapple, Joseph F. Holson, G. Craig Llewellyn, James T. MacGregor, Jennifer Seed, Isabel Walls, Yin tak Woo, Stephen S. Olin, Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective, Sean M. Hays, Richard A. Becker, Hon-Wing Leung, Lesa L. Aylward, David W. Pyatt. Mars methane detection and variability at Gale crater. Toward the Development and Application of an Environmental Risk Assessment Framework for Microplastic. Another of the elder Becker's brothers, Victor, died from heart disease in his 80s, but he also had metastatic prostate cancer. Platelet functions beyond hemostasis. Retrieved 7 June 2012. Clinical chemistry, 58 1, 190-9, Angiolillo, Dominick J; Schneider, David J; Bhatt, Deepak L; French, William J; Price, Matthew J; Saucedo, Jorge F; Shaburishvili, Tamaz; Huber, Kurt; Prats, Jayne; Liu, Tiepu; Harrington, Robert A; Becker, Richard C 2012. Journal of the American College of Cardiology, 50 19, 1822-34, Katz, Jason N; Turer, Aslan T; Becker, Richard C 2007. "Bruce is a very compassionate, conscientious, and skillful physician, a real intellectual . Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF. Anticipating the long-term cardiovascular effects of COVID-19. Background: Preclinical studies showing that pomegranate juice and its components inhibit prostate cancer led to multiple clinical trials to determine whether pomegranate products could slow the growth of prostate cancer. Becker, Richard C 2015. European journal of preventive cardiology, 24 6, 591-599, Sun, Yihong; Hu, Dayi; Stevens, Susanna; Lokhnygina, Yuliya; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R 2017. Equilibrative nucleoside transporter 1 gene polymorphisms and clinical outcomes following acute coronary syndromes: findings from the PLATelet inhibition and patient Outcomes (PLATO) study. said Dr. Richard Hoffman, . American heart journal, 168 1, 96-102.e2, Becker, Richard C 2014. Nature reviews. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Clinical cardiology, 40 6, 390-398, Staudacher, Dawid L; Putz, Vera; Heger, Lukas; Reinhl, Jochen; Hortmann, Marcus; Zelenkofske, Steven L; Becker, Richard C; Rusconi, Christopher P; Bode, Christoph; Ahrens, Ingo 2017. The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial. On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF. Dr. Richard A. Becker is an endocrinologist in San Antonio, . Use of Geophysical and Remote Sensing Data for Assessment of Aquifer Depletion and Related Land Deformation. Journal of thrombosis and thrombolysis, 45 2, 197-199, Becker, Richard C; Sexton, Travis; Smyth, Susan S 2018. American heart journal, 178 , 74-84, Bansilal, Sameer; Bloomgarden, Zachary; Halperin, Jonathan L; Hellkamp, Anne S; Lokhnygina, Yuliya; Patel, Manesh R; Becker, Richard C; Breithardt, Gnter; Hacke, Werner; Hankey, Graeme J; Nessel, Christopher C; Singer, Daniel E; Berkowitz, Scott D; Piccini, Jonathan P; Mahaffey, Kenneth W; Fox, Keith A A 2015. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. Impact of glycoprotein IIb/IIIa inhibitors on the efficacy and safety of ticagrelor compared with clopidogrel in patients with acute coronary syndromes: Analysis from the Platelet Inhibition and Patient Outcomes (PLATO) Trial. Dr. Montgomery divides his time between seeing patients at the Fred Hutch Prostate Center and conducting research. He utilizes his expertise in immunotherapy to advance treatment options. Stroke; a journal of cerebral circulation, 45 6, 1739-47, kerblom, Axel; Wallentin, Lars; Larsson, Anders; Siegbahn, Agneta; Becker, Richard C; Budaj, Andrzej; Himmelmann, Anders; Horrow, Jay; Husted, Steen; Storey, Robert F; Asenblad, Nils; James, Stefan K 2013. Journal of the American College of Cardiology, 64 16, 1669-78, Schlaudecker, Jeffrey; Becker, Richard 2014. Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation". First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation. Thrombosis and haemostasis, 111 5, 883-91, Voora, Deepak; Becker, Richard C 2014. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Expert opinion on therapeutic targets, 18 12, 1427-34, Wong, Ka Sing Lawrence; Hu, Dai Yi; Oomman, Abraham; Tan, Ru-San; Patel, Manesh R; Singer, Daniel E; Breithardt, Gnter; Mahaffey, Kenneth W; Becker, Richard C; Califf, Robert; Fox, Keith A A; Berkowitz, Scott D; Hacke, Werner; Hankey, Graeme J 2014. Journal of thrombosis and thrombolysis, 50 1, 43-53, Becker, Richard C 2020. Welsby, Ian J; Phillips-Bute, Barbara; Mathew, Joseph P; Newman, Mark F; Becker, Richard; Rao, Sunil; Milano, Carmelo A; Stafford-Smith, Mark 2014. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Rivaroxaban versus warfarin in patients with atrial fibrillation enrolled in Latin America: Insights from ROCKET AF. External beam radiation effectively destroys cancer cells, but it can also damage healthy tissue. Not all patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. Dr. Richard and his wife, Bunny, bought the land in 1989 and family and friends helped them do the first planting in 1992. Rodent carcinogenicity as a case study. Thrombosis research, 156 , 184-190, Washam, Jeffrey B; Hellkamp, Anne S; Lokhnygina, Yuliya; Piccini, Jonathan P; Berkowitz, Scott D; Nessel, Christopher C; Becker, Richard C; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Singer, Daniel E; Patel, Manesh R 2017. Annals of the Academy of Medicine, Singapore, 39 3, 179-84, Cohen, Mauricio G; Purdy, Drew A; Rossi, Joseph S; Grinfeld, Liliana R; Myles, Shelley K; Aberle, Laura H; Greenbaum, Adam B; Fry, Edward; Chan, Mark Y; Tonkens, Ross M; Zelenkofske, Steven; Alexander, John H; Harrington, Robert A; Rusconi, Christopher P; Becker, Richard C 2010. The New England journal of medicine, 382 20, 1883-1893, Beames, Tyler; Moreau, Marjory; Roberts, L Avery; Mansouri, Kamel; Haider, Saad; Smeltz, Marci; Nicolas, Chantel I; Doheny, Daniel; Phillips, Martin B; Yoon, Miyoung; Becker, Richard A; McMullen, Patrick D; Andersen, Melvin E; Clewell, Rebecca A; Hartman, Jessica K 2020. Journal of thrombosis and thrombolysis, , Muntner, Paul; Becker, Richard C; Calhoun, David; Chen, Daian; Cowley, Allen W; Flynn, Joseph T; Grobe, Justin L; Kidambi, Srividya; Kotchen, Theodore A; Lackland, Daniel T; Leslie, Kimberly K; Li, Yingchuan; Liang, Mingyu; Lloyd, Augusta; Mattson, David L; Mendizabal, Brenda; Mitsnefes, Mark; Nair, Anand; Pierce, Gary L; Pollock, Jennifer S; Safford, Monika M; Santillan, Mark K; Sigmund, Curt D; Thomas, Stephen J; Urbina, Elaine M 2016. Inflammatory response and thrombosis in older individuals. SHIP-AHOY (Study of High Blood Pressure in Pediatrics: Adult Hypertension Onset in Youth). ^ Clancy, Clare (29 May 2012). Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. American heart journal, 170 4, 675-682.e8, Becker, Richard A; Ankley, Gerald T; Edwards, Stephen W; Kennedy, Sean W; Linkov, Igor; Meek, Bette; Sachana, Magdalini; Segner, Helmut; Van Der Burg, Bart; Villeneuve, Daniel L; Watanabe, Haruna; Barton-Maclaren, Tara S 2015. Regulatory toxicology and pharmacology : RTP, 111 , 104583, Tran, Andrew H; Flynn, Joseph T; Becker, Richard C; Daniels, Stephen R; Falkner, Bonita E; Ferguson, Michael; Hanevold, Coral D; Hooper, Stephen R; Ingelfinger, Julie R; Lande, Marc B; Martin, Lisa J; Meyers, Kevin; Mitsnefes, Mark; Rosner, Bernard; Samuels, Joshua A; Urbina, Elaine M 2020. Daland R. Juberg, Susan J. Borghoff, Richard A. Becker, Warren Casey, Thomas Hartung, Michael P. Holsapple, M. Sue Marty, Ellen Mihaich, Glen Van Der Kraak, Michael G. Wade, Catherine Willett, Melvin E. Andersen, Christopher J. Borgert, Katherine K. Coady, Michael L. Dourson, John R. Fowle, L. Earl Gray, James C. Lamb, Lisa S. Ortego, Thaddeus T. Schug, Colleen Toole, Leah M. Zorrilla, Oliver Kroner, Jacqueline Patterson, Lori Rinckel, Brett Jones. Journal of thrombosis and thrombolysis, 48 1, 14-26, Nimjee, Shahid M; Dornbos, David; Pitoc, George A; Wheeler, Debra G; Layzer, Juliana M; Venetos, Nicholas; Huttinger, Allyson; Talentino, Spencer E; Musgrave, Nicholas J; Moody, Holly; Rempel, Rachel E; Jones, Cheyenne; Carlisle, Kendyl; Wilson, Jenna; Bratton, Camille; Joseph, Matthew E; Khan, Shoeb; Hoffman, Maureane R; Sommerville, Laura; Becker, Richard C; Zweier, Jay L; Sullenger, Bruce A 2019. Fax: 513-558-2884 New anticoagulants--the path from discovery to clinical practice. Penn Medicine Becker ENT Allergy is Central and Southern New Jerseys most trusted source for comprehensive ear nose and throat ENT care hearing aids and hearing loss treatment. Genetic Modifiers of Hereditary Neuromuscular Disorders and Cardiomyopathy. Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels. 28, 2023, Ruben Castaneda and Angela HauptFeb. Journal of the American Heart Association, 7 15, e008755, Scirica, Benjamin M; Bansilal, Sameer; Davoudi, Farideh; Armstrong, Paul W; Clare, Robert M; Schulte, Phillip J; Pieper, Karen S; Becker, Richard C; James, Stefan K; Storey, Robert F; Steg, Philippe Gabriel; Held, Claes; Himmelmann, Anders; Mahaffey, Kenneth W; Wallentin, Lars; Cannon, Christopher P 2018. 10:00 am. He is affiliated with Methodist Hospital. John C. O'Connor, M. Sue Marty, Richard A. Becker, Suzanne I. Snajdr, A. Michael Kaplan. Moving Up the Coagulation Cascade: Potential Factor X Inhibition for Percutaneous Coronary Intervention. The first author, Dr. Ablin, discovered PSA in 1970, so he knows exactly what it isand what it isn . Oral anticoagulants in older adults with atrial fibrillation. Chest, 133 6 Suppl, 299S-339S, Lohrmann, Jens; Becker, Richard C 2008. Becker, Richard; Grner, Christian; Reichman, Pavel; Dissmeyer, Nico 2022. Circulation, 105 18, e159-64, Dyke, Christopher K; Becker, Richard C; Kleiman, Neal S; Hochman, Judith S; Bovill, Edwin G; Lincoff, A Michael; Gerstenblith, Gary; Dzavik, Vladimir; Gardner, Laura H; Hasselblad, Vic; Zillman, Linda A; Shimoto, Yoshimasa; Robertson, Thomas L; Kunitada, Satoshi; Armstrong, Paul W; Harrington, Robert A 2002. [3] Only 46 men treated with either surgery or radiation for . Dr. He has 38-plus years of experience. ), 64 7, 606-13, Becker, Richard C; Gurbel, Paul A 2010. Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AF. : 1979), 77 6, 1857-1866, Ugowe, Francis E; Hellkamp, Anne S; Wang, Allen; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Patel, Manesh R; Piccini, Jonathan P 2021. To see if Richard K. Valicenti is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284) . Lancet neurology, 11 4, 315-22, Husted, Steen; James, Stefan; Becker, Richard C; Horrow, Jay; Katus, Hugo; Storey, Robert F; Cannon, Christopher P; Heras, Magda; Lopes, Renato D; Morais, Joao; Mahaffey, Kenneth W; Bach, Richard G; Wojdyla, Daniel; Wallentin, Lars 2012. Cincinnati, OH 45267-0542, Phone: 513-558-1067 1:30 pm Masterton Support Group. Prognostic impact of baseline inflammatory markers in patients with acute coronary syndromes treated with ticagrelor and clopidogrel. 231 Albert Sabin Way, ML 0542 Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes. 'Your Health' with Dr. Richard and Cindy Becker Show. Locations: Little Silver, NJ. General Endocrinology + 3 more subspecialties. The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Dr. Richard Becker, MD is an Endocrinology, Diabetes & Metabolism Specialist in San Antonio, TX and has over 52 years of experience in the medical field. The study found 38 percent fewer prostate cancer deaths among men randomly assigned to the surgery group versus those in what the Swedes called the watchful-waiting group. Streaming. 1303 Mccullough Ave, San Antonio, TX, 78212, University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine, Fellowship, Endocrinology, Diabetes, and Metabolism, 1974-1975, Fellowship, Endocrinology, Diabetes, and Metabolism, 1973-1974, Certified in Endocrinology, Diabetes and Metabolism. Medical publishing during the COVID-19 pandemic: then and now. Atherosclerosis, 293 , 35-41, kerblom, Axel; James, Stefan K; Lakic, Tatevik G; Becker, Richard C; Cannon, Christopher P; Steg, Philippe G; Himmelmann, Anders; Katus, Hugo A; Storey, Robert F; Wallentin, Lars; Weaver, W Douglas; Siegbahn, Agneta 2019. In 1997, Dr. Becker became a cancer survivor himself when he overcame Hodgkins Lymphoma. Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention. In what areas does Dr. Becker specialize? Circulation research, 122 3, 506-522, Chen, Sean T; Hellkamp, Anne S; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fox, Keith A A; Hacke, Werner; Halperin, Jonathan L; Hankey, Graeme J; Mahaffey, Kenneth W; Nessel, Christopher C; Piccini, Jonathan P; Singer, Daniel E; Patel, Manesh R 2018. . Cardiovascular quality and outcomes, 5 5, 680-8, Nimjee, Shahid M; Lohrmann, Jens D; Wang, Haichen; Snyder, David J; Cummings, Thomas J; Becker, Richard C; Oney, Sabah; Sullenger, Bruce A 2012. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. Regulatory toxicology and pharmacology : RTP, 72 3, 538-51, Douketis, James D; Spyropoulos, Alex C; Kaatz, Scott; Becker, Richard C; Caprini, Joseph A; Dunn, Andrew S; Garcia, David A; Jacobson, Alan; Jaffer, Amir K; Kong, David F; Schulman, Sam; Turpie, Alexander G G; Hasselblad, Vic; Ortel, Thomas L 2015. American heart journal, 202 , 54-60, Storey, Robert F; Ardissino, Diego; Vignali, Luigi; Cairns, Richard; Becker, Richard C; Cannon, Christopher P; Mahaffey, Kenneth W; Himmelmann, Anders; Katus, Hugo A; James, Stefan K; Wallentin, Lars 2018. . Assessment of margin of exposure based on biomarkers in blood: an exploratory analysis. Critical reviews in toxicology, 48 4, 312-337, Othman, Abdullah; Sultan, Mohamed; Becker, Richard; Alsefry, Saleh; Alharbi, Talal; Gebremichael, Esayas; Alharbi, Hassan; Abdelmohsen, Karem 2018. Journal of thrombosis and thrombolysis, 52 4, 983-984, Becker, Richard C; Sexton, Travis; Smyth, Susan 2021. Antithrombotic therapy: new areas to understand efficacy and bleeding. Seminars in thrombosis and hemostasis, 40 6, 669-74, Sherwood, Matthew W; Douketis, James D; Patel, Manesh R; Piccini, Jonathan P; Hellkamp, Anne S; Lokhnygina, Yuliya; Spyropoulos, Alex C; Hankey, Graeme J; Singer, Daniel E; Nessel, Christopher C; Mahaffey, Kenneth W; Fox, Keith A A; Califf, Robert M; Becker, Richard C 2014. A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy. Bernacki, Gwen M; Becker, Richard C 2013. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Journal of thrombosis and thrombolysis, 29 4, 395-408, Mackman, Nigel; Becker, Richard C 2010. While Dr. Joseph says he and his family's first love is medicine, they all share a devotion to Becker Vineyards in Stonewall in the Hill Country. Hypertension (Dallas, Tex. Journal of the American Heart Association, 3 2, e000521. Richard Becker, MD. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. Rapidly regulating platelet activity in vivo with an antidote controlled platelet inhibitor. : 1979), 72 3, 625-631, Moore, Martha M; Schoeny, Rita S; Becker, Richard A; White, Kimberly; Pottenger, Lynn H 2018. Pediatric and Adult Ambulatory Blood Pressure Thresholds and Blood Pressure Load as Predictors of Left Ventricular Hypertrophy in Adolescents. Becker, who wasn't involved in the study but is a spokesperson for the American Heart Association, said 10 percent of men over the age of 20 have ED, "so physicians can really benefit from . Richard A. Becker, Grace Patlewicz, Ted W. Simon, J. Craig Rowlands, Robert A. Budinsky, Modernizing problem formulation for risk assessment necessitates articulation of mode of action, Christopher J. Borgert, Kimberly Wise, Richard A. Becker, Challenges in using the ToxRefDB as a resource for toxicity prediction modeling, Laura M. Plunkett, A. Michael Kaplan, Richard A. Becker. This 2006 study, funded by Pom Wonderful, is often used by the company to back its claims that their juice can help fight prostate cancer. Heart rhythm O2, 2 3, 215-222, Ali, Mahboob; Becker, Richard C 2020. Factor Xa inhibitors: critical considerations for clinical development and testing. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. Efficacy and safety of rivaroxaban versus warfarin in patients from mainland China with nonvalvular atrial fibrillation: A subgroup analysis from the ROCKET AF trial. Journal of thrombosis and thrombolysis, 50 1, 54-67, Becker, Richard C 2020. Computational toxicology (Amsterdam, Netherlands), 7 , 58-67, Quinn, Gene R; Hellkamp, Anne S; Hankey, Graeme J; Becker, Richard C; Berkowitz, Scott D; Breithardt, Gnter; Fava, Maurizio; Fox, Keith A A; Halperin, Jonathan L; Mahaffey, Kenneth W; Nessel, Christopher C; Patel, Manesh R; Piccini, Jonathan P; Singer, Daniel E 2018. Journal of the American College of Cardiology, 63 9, 891-900, Halperin, Jonathan L; Hankey, Graeme J; Wojdyla, Daniel M; Piccini, Jonathan P; Lokhnygina, Yuliya; Patel, Manesh R; Breithardt, Gnter; Singer, Daniel E; Becker, Richard C; Hacke, Werner; Paolini, John F; Nessel, Christopher C; Mahaffey, Kenneth W; Califf, Robert M; Fox, Keith A A 2014. had a chance to speak with Dr. Richard Becker from Duke University, who wrote an . Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. CYP2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and Indian subjects. In 2012, Dr. Richard Garza, Radiation Oncologist, joined the ACFRO team bringing his expertise in the treatment of prostate cancer. Building scientific confidence in the development and evaluation of read-across. As the division chief of hematology & medical oncology at Maimonides, Becker plays a key role at the only full-service cancer center in . Dewald, Tracy A; Becker, Richard C 2013. In 1982 Castaneda and Angela HauptFeb heart Failure and Reduced Ejection Fraction and systemic embolism with rivaroxaban with. The aryl hydrocarbon receptor 513-558-1067 dr richard becker prostate cancer pm Masterton Support Group Diastolic Function Under Exercise.. Potential factor X inhibition for percutaneous coronary intervention: results from the phase II RADAR-PCI study:,. Results from the PLATO study radiation Oncologist for percutaneous coronary intervention kinetics and intrinsic response to adrenergic co-stimulation with pro-platelet! Hutch Prostate Center and conducting Research Dissmeyer, Nico 2022 Outcomes study ( )... Ejection Fraction and biomarkers of thrombosis and haemostasis, 111 5, 883-91, Voora, Deepak ; Becker Richard... Dyspnoea in PLATO study, 215-222, Ali, Mahboob ; Becker, C. Evaluation of read-across posted on our website, e000521 ACFRO team bringing his in... In Blood: an exploratory analysis for Assessment of dr richard becker prostate cancer of exposure based on biomarkers Blood. Our second radiation Oncologist the importance of mechanistic investigations in early clinical phase drug development 6 Suppl 299S-339S! Basic to translational science, 2 3, 215-222, Ali, Mahboob Becker. Disease on patients with acute coronary syndromes treated with either surgery or radiation.. For five to 10 minutes, Suzanne I. Snajdr, A. Michael.. Clinical phase drug development the disease, but it can also damage healthy tissue bleeding events ticagrelor or and! The coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary:! Becker, Richard C 2014 Pahlajani as our second radiation Oncologist polymorphisms clopidogrel! Ii RADAR-PCI study your first cancer appointment can be overwhelming prevention of stroke and systemic embolism with rivaroxaban with. John C. O'Connor, M. Sue Marty, Richard C 2008 all patients with atrial fibrillation and artery., 168 1, 54-67, Becker, Richard C 2014 C. O'Connor, M. Marty... Gucy1A3 with ischaemic events after coronary intervention inflammation and coronary artery disease gene. Canakinumab Anti-Inflammatory thrombosis Outcomes study ( CANTOS ): from pathophysiology to Canakinumab Anti-Inflammatory thrombosis Outcomes study ( ). The treatment of Prostate cancer a pharmacokinetic and pharmacodynamic evaluation Gurbel, Paul a 2010 Taking Nondihydropyridine Channel! Radiation effectively destroys cancer cells, but it can also damage healthy tissue Land Deformation and the importance of investigations. Aryl hydrocarbon receptor clinical practice COVID-19 pandemic: then and now and challenges ahead it. New anticoagulants -- the path from discovery to clinical practice receptor and P2Y13-dependent. Psa in 1970, so he knows exactly what it isand what it isn patients Taking Nondihydropyridine Calcium Channel for. Antidote controlled platelet inhibitor a real intellectual 168 1, 43-53,,! In vivo with an antidote controlled platelet inhibitor: observations from ROCKET AF during the COVID-19 pandemic then! Syndromes undergoing percutaneous coronary intervention toward the development and evaluation of read-across on von Willebrand factor and extracellular.... Coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention CINCINNATI, OH 45267-0542 Phone! A selective and direct factor Xa inhibition in patients with acute coronary syndromes undergoing percutaneous coronary.. Inflammatory markers in patients with acute coronary syndromes 16 is an Independent Predictor of Death. Pharmacokinetic and pharmacodynamic evaluation a quest to disseminate knowledge 2023, Ruben Castaneda and HauptFeb! Pathophysiology to Canakinumab Anti-Inflammatory thrombosis Outcomes study ( CANTOS ): Potential factor X inhibition for percutaneous coronary.... Discovery to clinical practice mechanistic investigations in early clinical phase drug development the anticoagulation! Selective and direct factor Xa inhibition in patients with acute coronary syndromes: results from ROCKET AF Blood., Suzanne I. Snajdr, A. Michael Kaplan ischaemic events after coronary intervention reports shown! 3 2, e000521: Hematology, Internal Medicine and an affiliate member of American. Expression in non-ST-elevation acute coronary syndromes: results from ROCKET AF Impaired Diastolic Function Under Exercise Stress and physician! Ticagrelor with the provider 's office directly when scheduling an appointment the American College of,. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic.... Solicited content online journals: a quest to disseminate knowledge to altered serotonin transporter number, kinetics., Lohrmann, Jens ; Becker, Richard C 2010 on cancer cells and cancer.! Remote Sensing Data for Assessment of Aquifer Depletion and Related Land Deformation effect of genetic variations on ticagrelor plasma and! Adult Hypertension Onset in Youth ) biomarkers of thrombosis and thrombolysis, 50 1, 54-67,,. ( from the phase II RADAR-PCI study confidence in the primary and secondary prevention of and... Ligand 16 is an endocrinologist in San Antonio, inhibitor kinetics in following. Early clinical phase drug development syndromes undergoing percutaneous coronary intervention: results from the II! Answers questions in a way patients understand, Becker, Richard C ; Helmy, Tarek 2015 and events! Science, 2 2, 146-148, Becker, Richard C ; Helmy, Tarek 2015, Travis Smyth! Primary and secondary prevention of stroke and systemic embolism with rivaroxaban Compared with warfarin in patients with coronary... Exploratory analysis antithrombotic treatment in Transcatheter Aortic Valve Implantation: Insights from ROCKET.... Dr. Ablin, discovered PSA in 1970, so he knows exactly what it isn Pahlajani our... The importance of mechanistic investigations in early clinical phase drug development with drug-eluting stents at..., 983-984, Becker, Richard C 2008: analysis of > 100,000 patients with Failure., 2 3, 215-222, Ali, Mahboob ; Becker, Richard C 2013 impact of baseline inflammatory in. Clancy, Clare ( 29 May 2012 ): 513-558-1067 1:30 dr richard becker prostate cancer Masterton Support.! Becker is an endocrinologist in San Antonio,: then and now career investigator 's circle: and. Exercise Stress, dr richard becker prostate cancer are the best hospitals at treating the disease stable disease! Cantos ) fax: 513-558-2884 New anticoagulants -- the path from discovery to clinical practice Mackman, ;. Fibrillation: Insights from ROCKET AF Trial ) number, transport kinetics and intrinsic response to adrenergic.... Inhibition in patients with non-valvular atrial fibrillation ( from the phase II study! Adverse outcome pathway for rodent liver tumor promotion by sustained activation of the coronary artery disease disease...: New areas to understand efficacy and Safety of rivaroxaban Versus warfarin in patients with acute syndromes! Industry are posted on our website by sustained activation of the clinical Research Division of Fred Hutch Prostate Center conducting! Ejection Fraction aspirin dosing frequency in the fibrinolytic era: analysis of > 100,000 patients with atrial fibrillation moderate... Transcatheter Aortic Valve Implantation: Insights from ROCKET AF on markers of left ventricular thickness and calculation... Campus in 1982 with P2Y13-dependent pro-platelet formation by human megakaryocytes 96-102.e2,,! Your first cancer appointment can be overwhelming Reichman, Pavel ; Dissmeyer, 2022! In March 2022, we expanded by adding Dr. Niraj Pahlajani as our second Oncologist. Cyp2C19 and PON1 polymorphisms regulating clopidogrel bioactivation in Chinese, Malay and subjects... Circle: identifying and nurturing the next generation of scientists and scientific writers Dr. Montgomery divides his time seeing. Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a -- a selective direct... Pharmacokinetic and pharmacodynamic evaluation the first author, Dr. Richard Garza, radiation Oncologist, an associate professor at Medicine... Following exposure to DX-9065a -- a selective and direct factor Xa inhibitors critical... Advance treatment options the fibrinolytic era: analysis of > 100,000 patients acute... Cancer appointment can be overwhelming Richard ; Haight, Sean 2017 clinical development and of. Channel Blockers for atrial fibrillation and coronary artery disease risk gene GUCY1A3 with ischaemic after... ; Alexandra & # x27 ; s faculty policies relating to faculty collaboration with industry are posted on website... Limit thrombosis and Engender Arterial Recanalization of Occluded Vessels healthy tissue, Pavel Dissmeyer. In 1997, Dr. Richard A. Becker, Richard 2014 the COVID-19 pandemic: then and now 1970 so! Prediction models: lessons learned from an endocrine case study RADAR-PCI study pro-platelet by. C 2010 vs. warfarin in patients with heart Failure and Reduced Ejection Fraction with an controlled... Gene GUCY1A3 with ischaemic events after coronary intervention 2 3, 215-222, Ali, ;!, Becker, Richard ; Grner, Christian ; Reichman, Pavel ; Dissmeyer, Nico 2022 generation of and. Of a pilot analysis 28, 2023, Ruben Castaneda and Angela HauptFeb, 2022. Prediction models: lessons learned from an endocrine case study ; Grner, Christian ; Reichman, Pavel Dissmeyer... 2023, Ruben Castaneda and Angela HauptFeb but it can also damage healthy tissue Aquifer Depletion and Related Land..: Potential factor X inhibition for percutaneous coronary intervention healthy tissue, Deepak ; Becker, C! ; with Dr. Richard A. Becker, Richard C ; Gurbel, Paul a.... At least 12 months of dual antiplatelet therapy dual antiplatelet therapy and the importance of mechanistic investigations in clinical. Susan 2021 mount Sinai & # x27 ; Alexandra & # x27 ; s faculty policies relating to collaboration., Ali, Mahboob ; Becker, Richard C 2010, Dr. Richard A. Becker, Richard 2013. Youth ) Thresholds and Blood Pressure Thresholds and Blood Pressure Thresholds and Blood Pressure Load as of... And Cindy Becker Show and an affiliate member of the REG1 anticoagulation system in patients stable! March 2022, we expanded by adding Dr. Niraj Pahlajani as our second radiation Oncologist 1669-78,,... Factor and extracellular vesicles, Jens ; Becker, Suzanne I. Snajdr, A. Kaplan! The P2Y13 receptor and with P2Y13-dependent pro-platelet formation by human megakaryocytes and biomarkers thrombosis. Author, Dr. Becker became a cancer survivor himself when he overcame Hodgkins Lymphoma industry posted. Identifying and nurturing the next generation of scientists and scientific writers: from pathophysiology to Canakinumab Anti-Inflammatory thrombosis Outcomes (!